Search

Your search keyword '"Cornberg, Markus"' showing total 1,451 results

Search Constraints

Start Over You searched for: Author "Cornberg, Markus" Remove constraint Author: "Cornberg, Markus"
1,451 results on '"Cornberg, Markus"'

Search Results

4. Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States

7. Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial

9. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta

10. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure

13. HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy

15. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

16. Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022

17. Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study

18. Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B

19. A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B

20. Treating hepatitis D with bulevirtide – Real-world experience from 114 patients

22. Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19

23. Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial

27. TOP-400 Impact of bulevirtide given with or without nucleos (t)ide analogues on 48-week virologic outcomes in patients with chronic hepatitis delta virus infection

29. SAT-363 Hepatocellular carcinoma development post hepatitis C virus cure is associated with distinct changes in the dynamics of the soluble inflammatory milieu

31. FRI-107-YI Folic acid prescription is associated with a lower mortality and hospital readmission in patients with decompensated alcohol-related liver cirrhosis

32. SAT-533 Liver immunity index: predicting immune control of chronic hepatitis B from circulating CD8 T cells

34. WED-392 Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48weeks of bulevirtide monotherapy

35. LBP-029 Efficacy and safety of 144 weeks of bulevirtide 2 mg or 10 mg monotherapy from the ongoing phase 3 study, MYR301

36. Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial

37. Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study

38. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

41. Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)

42. Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study)

43. No value of non‐selective beta‐blockers after TIPS‐insertion.

44. Long‐term outcome of hepatitis delta in different regions world‐wide: Results of the Hepatitis Delta International Network.

45. Host response to influenza infections in human blood: association of influenza severity with host genetics and transcriptomic response.

49. Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment

Catalog

Books, media, physical & digital resources